News
New biomarker model outmatches conventional risk factors for predicting mortality
August 20, 2019
Although the majority of these biomarkers have been associated with mortality before, this is the first study that shows their independent effect when combined into one model.
News
Post-TAVR anticoagulation alone fails to cut stroke risk in AFib
August 19, 2019
By contrast, antiplatelet therapy linked to reduced risk of stroke, whether or not oral anticoagulation was used in this PARTNER II substudy.
![1]()
News
Study: Cardiac biomarkers predicted CV events in CAP
August 13, 2019
The results suggest a change in usual practice is needed to reduce cardiovascular community-acquired pneumonia complications, according to a study author.
News
Algorithm boosts MACE prediction in patients with chest pain
August 12, 2019
High-sensitivity cardiac troponin measurements combined with ECG and clinical assessment can help rule out MACE and unstable angina.
![1]()
News
Sepsis survivors’ persistent immunosuppression raises mortality risk
August 7, 2019
Individuals with persistent biomarkers of inflammation and immunosuppression had a higher risk of readmission and death because of cardiovascular disease.
![1]()
News
Older patients who stop statins may be increasing their cardiovascular risk
August 2, 2019
Discontinuation of statins was associated with an increased risk of hospital admission for a cardiovascular event.
News
AI technology meets AFib detection
August 2, 2019
An AI-enabled ECG model suggests clinical implications for early identification of atrial fibrillation.
![1]()
News
Most patients with new hypertension under revised BP guidelines won’t need pharmacotherapy
July 29, 2019
ORLANDO – In terms of nonpharmacologic therapies for these patients, the largest benefit is in getting them to lose weight.
![1]()
News
NSAID use in high-risk patients not linked with short-term, safety-related adverse event
July 26, 2019
In patients with hypertension, chronic kidney disease, or heart failure presenting with a musculoskeletal disorder, how frequently are prescription NSAIDs dispensed and are there associated short-term (between 7-38 days of visit) safety-related outcomes?
![1]()
News
Efficacy of DOACs vs. warfarin in high-risk atrial fibrillation patients
July 25, 2019
Are the direct-acting anticoagulants (DOACs) rivaroxaban and dabigatran efficacious and safe, compared with warfarin, in elderly atrial fibrillation patients with new-onset atrial fibrillation and multiple major comorbidities?
